SQUAWK/NEWS
Menu
Live News EQUITY L impact

Lakewood-Amedex Files 424B3

Lakewood-Amedex Biotherapeutics files prospectus supplement with SEC. Filing provides updated information on company's securities.

LAKW

Filed: 2026-05-26 AccNo: 0001213900-26-061018 Size: 376 KB